Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Pediatric Endocrinology

Standard of Care: Treating with Levothyroxine

At a Glance

Babies with dyshormonogenic goiter are usually treated promptly with daily levothyroxine, with doses adjusted using TSH and free T4 blood tests. Some genetic forms, including DUOX2-related disease, may be reassessed around age 3 for a supervised trial off treatment.

Because your baby’s thyroid gland is present but not producing enough hormone, the standard of care is to provide that hormone in the form of a daily medication called levothyroxine [1]. This is a synthetic version of the natural hormone your baby’s body needs for growth and brain development [1].

Starting Treatment Promptly

Time is of the essence when treating congenital hypothyroidism. Medical guidelines recommend starting levothyroxine as soon as the diagnosis is confirmed, ideally within the first two weeks of life [1][2].

  • The Initial Dose: For most newborns, the recommended starting dose is 10 to 15 micrograms per kilogram (mcg/kg) per day [3][4]. Your doctor will calculate the exact dose based on your baby’s weight and the severity of their test results.
  • Don’t Wait for Scans: Treatment should begin even if imaging (like an ultrasound or scan) or genetic testing has not yet been completed [1]. The priority is getting the hormone levels into a healthy range for your baby’s brain [5].

Monitoring and Targets

In the first few years of life, your baby’s brain is rapidly developing, making consistent hormone levels critical [5]. Your medical team will use frequent blood tests to monitor two main levels:

  1. TSH: The goal is typically to keep this in the normal range for an infant [3][2].
  2. Free T4: Doctors generally aim to keep this level in the upper half of the infant-specific reference range [3][2].

You can expect blood tests to be quite frequent in the beginning. Your first follow-up blood test will typically be about 1 to 2 weeks after starting the medication to ensure the dose is right. After that, tests are often every 1 to 2 months during the first year, and 4 to 6 weeks after any dose change [6][1].

Giving the Medication Correctly

For the medication to work, your baby’s body must be able to absorb it fully. Giving a daily pill to an infant requires a specific routine:

  • Administration: Crush the tablet completely and give it with a very small amount (1-2 teaspoons) of water, breastmilk, or formula using an oral syringe or a small spoon. Never mix the medication into a full bottle, as your baby might not finish it and will miss some of the dose. Ask your doctor for their specific protocol for spit-ups or missed doses—do not “double up” a missed dose unless instructed.
  • Consistency: Give the medication at the same time every day and keep its relationship to feeding consistent [5].
  • Interferences: Be aware that certain formula thickeners (like carob bean gum), soy-based formulas, and supplements containing iron or calcium can reduce how much medication gets into the blood [5][7]. Always check with your endocrinologist before starting new supplements or changing formula types.
  • Adherence: Missing doses can lead to periods of low thyroid hormone, which may impact development over time [5][8].

Reassessing at Age Three

In some cases of dyshormonogenic goiter, the condition may be transient, meaning the thyroid might eventually start working on its own [9][10]. This is more common with certain genetic types, such as those involving the DUOX2 gene [10].

Because it is difficult to tell in infancy if the condition is permanent, if your doctor suspects a transient form, they may wait until the child is about 3 years old to investigate further [11]. At this age, the most critical window of brain development has passed.

  • The Trial: Under strict medical supervision, the doctor may trial a “withdrawal” or a pause in the medication [11][12].
  • Testing: During this time, the doctor will monitor blood levels closely to see if the child’s thyroid can maintain normal hormone levels on its own [13].
  • Warning: Never stop or change your child’s medication on your own. A trial off medication is not universally required and should only be done when your pediatric endocrinologist determines it is safe and has a plan for monitoring [10].

If the thyroid cannot keep up, the medication is simply restarted, and the child continues to grow and develop normally [3].

Common questions in this guide

What is the usual treatment for dyshormonogenic goiter in a baby?
The standard treatment is daily levothyroxine, a synthetic form of thyroid hormone, because the baby's thyroid is not making enough hormone. Starting treatment promptly supports normal growth and brain development.
How soon should a baby start levothyroxine, and what dose is typical?
Treatment is generally started as soon as congenital hypothyroidism is confirmed, ideally within the first two weeks of life. A common starting dose is 10 to 15 micrograms per kilogram each day, but the baby's doctor determines the exact dose from weight and test results.
How should I give levothyroxine to my baby?
Crush the tablet completely and give it with a small amount of water, breastmilk, or formula using an oral syringe or small spoon. Do not mix it into a full bottle, and keep the timing relative to feeds consistent. Ask the doctor what to do after spit-up or a missed dose, and do not give an extra dose unless instructed.
Can formula or supplements interfere with levothyroxine absorption?
Yes. Soy-based formula, some thickeners containing carob bean gum, and supplements with iron or calcium can reduce how much levothyroxine the body absorbs. Check with the baby's endocrinologist before changing formula or starting a supplement.
How often will my baby need thyroid blood tests?
The first follow-up test is usually done about one to two weeks after treatment begins. Testing is often repeated every one to two months during the first year and four to six weeks after a dose change, using TSH and free T4 to guide treatment.
Could my child eventually stop taking levothyroxine?
Some cases of dyshormonogenic goiter are temporary, including some related to changes involving the DUOX2 gene. If the pediatric endocrinologist believes a trial is safe, medication may be paused around age three with close blood-test monitoring. Never stop levothyroxine without a medical plan.

Get notified when new evidence is published on dyshormonogenic goiter.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update-An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology.

    van Trotsenburg P, Stoupa A, Léger J, et al.

    Thyroid : official journal of the American Thyroid Association 2021; (31(3)):387-419 doi:10.1089/thy.2020.0333.

    PMID: 33272083
  2. 2

    Evaluation and management of the child with hypothyroidism.

    Leung AKC, Leung AAC

    World journal of pediatrics : WJP 2019; (15(2)):124-134 doi:10.1007/s12519-019-00230-w.

    PMID: 30734891
  3. 3

    Congenital Hypothyroidism: Screening and Management.

    Rose SR, Wassner AJ, Wintergerst KA, et al.

    Pediatrics 2023; (151(1)) doi:10.1542/peds.2022-060419.

    PMID: 36827523
  4. 4

    Congenital Hypothyroidism: Optimal Initial Dosage and Time of Initiation of Treatment: A Systematic Review.

    Rahmani K, Yarahmadi S, Etemad K, et al.

    International journal of endocrinology and metabolism 2016; (14(3)):e36080 doi:10.5812/ijem.36080.

    PMID: 27942261
  5. 5

    An Overview on Different L-Thyroxine (l-T4) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.

    Stagi S, Municchi G, Ferrari M, Wasniewska MG

    Frontiers in endocrinology 2022; (13()):859487 doi:10.3389/fendo.2022.859487.

    PMID: 35757415
  6. 6

    Frequency of thyroid status monitoring in the first year of life and predictors for more frequent monitoring in infants with congenital hypothyroidism.

    Zdraveska N, Anastasovska V, Kocova M

    Journal of pediatric endocrinology & metabolism : JPEM 2016; (29(7)):795-800.

    PMID: 27089409
  7. 7

    Worsening of Congenital Hypothyroidism After Start of Carob-bean Gum Thickened Formula: Is There a Link? A Case Report

    Signorino C, Municchi G, Ferrari M, Stagi S

    Journal of clinical research in pediatric endocrinology 2025; (17(2)):237-241 doi:10.4274/jcrpe.galenos.2023.2023-9-12.

    PMID: 38054412
  8. 8

    Relation between Early Over- and Undertreatment and Behavioural Problems in Preadolescent Children with Congenital Hypothyroidism.

    Bongers-Schokking JJ, Resing WCM, Oostdijk W, et al.

    Hormone research in paediatrics 2018; (90(4)):247-256 doi:10.1159/000494056.

    PMID: 30408796
  9. 9

    Complicated Relationship between Genetic Mutations and Phenotypic Characteristics in Transient and Permanent Congenital Hypothyroidism: Analysis of Pooled Literature Data.

    Long W, Zhou L, Wang Y, et al.

    International journal of endocrinology 2020; (2020()):6808517 doi:10.1155/2020/6808517.

    PMID: 32565793
  10. 10

    Natural course of congenital hypothyroidism by dual oxidase 2 mutations from the neonatal period through puberty.

    Maruo Y, Nagasaki K, Matsui K, et al.

    European journal of endocrinology 2016; (174(4)):453-63 doi:10.1530/EJE-15-0959.

    PMID: 26742565
  11. 11

    50 YEARS OF NEWBORN SCREENING FOR CONGENITAL HYPOTHYROIDISM: EVOLUTION OF INSIGHTS IN ETIOLOGY, DIAGNOSIS AND MANAGEMENT: Transient or permanent congenital hypothyroidism: from milestones to current and future perspectives.

    Vincenzi G, Petralia IT, Abbate M, Vigone MC

    European thyroid journal 2025; (14(4)).

    PMID: 40686339
  12. 12

    Permanent or Transient Congenital Hypothyroidism: A Diagnostic Dilemma.

    Dermitzaki N, Serbis A, Baltogianni M, et al.

    Acta paediatrica (Oslo, Norway : 1992) 2026; (115(1)):43-54 doi:10.1111/apa.70312.

    PMID: 40976938
  13. 13

    The evaluation of transient hypothyroidism in patients diagnosed with congenital hypothyroidism.

    Peltek Kendirci HN, Aycan Z, Sağsak E, et al.

    Turkish journal of medical sciences 2015; (45(4)):745-50.

    PMID: 26422840

This page explains levothyroxine treatment and monitoring for babies with dyshormonogenic goiter for informational purposes only; it does not replace medical advice from your baby's pediatric endocrinologist.